Track: Vitiligo Treatment

Vitiligo poses distinct challenges in dermatology, requiring a combination of medical management and psychological support for those affected. Although the exact cause remains elusive, recent advancements have improved the effectiveness of treatment options. Topical therapies, including corticosteroids and immunomodulators, are vital in slowing the progression of depigmentation. Phototherapy techniques, such as narrowband UVB, have also demonstrated potential in repigmenting affected areas. The focus will be on these therapeutic strategies, providing insights into their mechanisms, advantages, and limitations.

Topical Corticosteroids:

Topical corticosteroids are often the first line of treatment for vitiligo, helping to reduce inflammation and slow the progression of depigmentation. This approach is particularly effective for localized vitiligo, though long-term use requires careful monitoring to avoid potential side effects like skin thinning.

Immunomodulators:

Immunomodulators, such as topical calcineurin inhibitors, offer an alternative to corticosteroids, particularly for sensitive areas like the face and neck. These agents work by modulating the immune response, reducing the autoimmune activity that contributes to the loss of skin pigment without the risk of skin atrophy associated with steroids.

Narrowband UVB Phototherapy:

Narrowband UVB phototherapy is a widely used treatment for vitiligo, especially in cases where large areas of the body are affected. This method involves exposing the skin to specific wavelengths of ultraviolet light, which stimulates melanocyte activity and promotes repigmentation. Although effective, the treatment requires multiple sessions and can take several months to achieve noticeable results.

3rd International Conference on Dermatology and Cosmetology

Track: Vitiligo Treatment

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at